Dilatation of the COLON, often to alarming dimensions. There are various types of megacolon including congenital megacolon in HIRSCHSPRUNG DISEASE, idiopathic megacolon in CONSTIPATION, and TOXIC MEGACOLON.
An acute form of MEGACOLON, severe pathological dilatation of the COLON. It is associated with clinical conditions such as ULCERATIVE COLITIS; CROHN DISEASE; AMEBIC DYSENTERY; or CLOSTRIDIUM ENTEROCOLITIS.
Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.
Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
A segment of the COLON between the RECTUM and the descending colon.
Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)
Excision of a portion of the colon or of the whole colon. (Dorland, 28th ed)
The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
Surgical creation of an external opening into the ILEUM for fecal diversion or drainage. This replacement for the RECTUM is usually created in patients with severe INFLAMMATORY BOWEL DISEASES. Loop (continent) or tube (incontinent) procedures are most often employed.
The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON.
The surgical construction of an opening between the colon and the surface of the body.

Effects of octreotide on responses to colorectal distension in the rat. (1/23)

BACKGROUND AND AIMS: It has been suggested that the analgesic effect of the somatostatin analogue octreotide in visceral pain involves peripheral mechanisms. We evaluated the effect of octreotide on responses to noxious colorectal distension in rats. METHODS: In a behavioural study, pressor and electromyographic responses to colorectal distension were evaluated before and after intravenous or intrathecal administration of octreotide. In pelvic nerve afferent fibre recordings, responses of mechanosensitive fibres innervating the colon to noxious colorectal distension (80 mm Hg, 30 seconds) were tested before and after octreotide. RESULTS: Octreotide was ineffective in attenuating responses to colorectal distension in either normal or acetic acid inflamed colon when administered intravenously but attenuated responses when given intrathecally. Administration of octreotide over a broad dose range (0.5 microg/kg to 2.4 mg/kg) did not alter responses of afferent fibres to noxious colorectal distension in untreated, or acetic acid or zymosan treated colons. CONCLUSIONS: In the rat, octreotide has no peripheral (pelvic nerve) modulatory action in visceral nociception. The antinociceptive effect of octreotide in this model of visceral nociception is mediated by an action at central sites.  (+info)

Blood pH: a test for assessment of severity in proctocolitis. (2/23)

Acid base balance was studied in 58 patients with active idiopathic proctocolitis; the condition of 10 of them was complicated by toxic megacolon. Arterial blood pH increased progressively with increased severity of the colitis and as the lesions became more widespread. Statistically significant differences were observed in pH values between the mild/moderate and severe forms and between the severe and complicated forms ('toxic megacolon'). A linear correlation was found between pH and the amount of intestinal gas, pulse rate, and plasma albumin.  (+info)

Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis. (3/23)

AL amyloidosis is a plasma cell disorder in which tissue deposition of immunoglobulin light chains leads to organ dysfunction. Recent reports of high-dose therapy with autologous stem cell transplantation for amyloidosis suggest higher response rates and extended survival compared to those seen with conventional chemotherapy. However, substantial treatment-related toxicity has been observed. This case series describes our institutional experience with autologous transplantation in four patients with amyloidosis with an emphasis on unique gastrointestinal toxicities, including toxic megacolon.  (+info)

Ulcerative colitis developing after amoebic dysentery in a haemophiliac patient with AIDS. (4/23)

Severe diarrhoea in patients with the acquired immune deficiency syndrome (AIDS) is usually a manifestation of gastrointestinal infection by a variety of organisms. We report a patient with low CD4 T cell counts who developed ulcerative colitis after amoebic dysentery. He subsequently developed acute ulcerative colitis with toxic dilatation while he was severely immunocompromised. He responded to corticosteroids and mesalazine and remains well on maintenance therapy.  (+info)

Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India. (5/23)

BACKGROUND: Steroid-based intensive medical therapy for severe ulcerative colitis is successful in 60-70% of such patients. Patients with complications or those refractory to medical therapy require emergency colectomy for salvage. Little is known about the impact of timing of surgical intervention and surgical outcomes of such patients undergoing emergency surgery in India where the diagnosis is often delayed or missed in patients who are poor, malnourished and non-compliant to medical treatment. METHODS: The clinical records of all patients undergoing emergency surgery for severe ulcerative colitis or its complication in the Department of GI surgery AIIMS, New Delhi, India, between January 1985 and December 2003 were retrieved and data pertaining to demographic features, duration of intensive medical therapy, presence of complications, time from admission to emergency surgery, surgical procedure, in-hospital morbidity and mortality and follow up status extracted. RESULTS: A total of 72 patients underwent emergency surgery (Subtotal colectomy: 60; ileostomy alone under local anaesthesia: 12). Poor nutritional status was seen in 61% of the patients. Twenty-one patients (29%) underwent emergency surgery for complications of severe ulcerative colitis such as colonic perforation (spontaneous 6, iatrogenic 4), massive lower gastrointestinal haemorrhage (5), toxic megacolon (4) and large bowel obstruction (2). The remaining patients (n = 51) underwent emergency surgery following failed intensive therapy; 17 underwent surgery < or = 5 days (Group I) and 34 were operated > 5 days (Group II) after initiation of intensive therapy. In this group all the post-operative deaths (n = 8) occurred in those who were operated after 5 days. The difference in mortality in these two groups (i.e. surgical intervention < or = or > 5 days) was statistically significant {0/17 (Group I) vs 8/34 (Group II); p = 0.03}. Overall, 12 patients died (in-hospital mortality: 16.7%). The mortality was higher (10/43; 23.3%) in our early experience (i.e. 1985-1995) when compared to our subsequent experience (2/29; 6.9%) (1996-2003). A total of 48 patients (including 3 awaiting a restorative procedure) are alive on follow up (66.7%; 3 patients lost to follow up). A restorative procedure could be successfully completed in 81% of the survivors of the emergency procedure. CONCLUSION: To optimize the outcome, a combined team of physicians and surgeons should be involved in the management of patients with severe ulcerative colitis with focus on nutritional support, correction of metabolic derangements, close clinical monitoring and timely assessment for the need for emergency surgery. This retrospective analysis shows that improved results can be achieved with experience and by following a policy of early surgical intervention within 5 days, especially in patients who have failed intensive medical therapy.  (+info)

Acute thrombocytopenia associated with preexisting ulcerative colitis successfully treated with colectomy. (6/23)

We report a case of successfully treated acute thrombocytopenia associated with preexisting ulcerative colitis (UC). The patient had typical symptoms of UC, and colonoscopy showed pancolitis. During treatment with sulfasalazopyridine (SASP) and steroids, thrombocytopenia was observed. Despite the cessation of drugs, severe thrombocytopenia was noted. Immune thrombocytopenic purpura (ITP) was suspected based on a normal bone marrow megakaryocyte count, positive autoantibody to platelet membrane antigen, and the absence of splenomegaly. Medical treatment, including increased dosage of steroids, failed to control UC and acute thrombocytopenia in this patient. Moreover, acute severe pancreatitis developed and abdominal computed tomography showed toxic megacolon. Platelet count recovered after urgent total colectomy without splenectomy. When patients with UC develop thrombocytopenia, particularly in the presence of extensive and significant colonic inflammation, a diagnosis of ITP should be considered. In such patients, preexisting UC might be involved in the immunological causal mechanism of ITP. In this situation, colectomy might cure both UC and resistant thrombocytopenia. Steroid-refractory and life-threatening UC complicated by thrombocytopenia presumably caused by ITP is therefore a possible indication for colectomy.  (+info)

Established and potential risk factors for Clostridum difficile infection. (7/23)

 (+info)

Toxic megacolon complicating a Clostridium difficile infection in a pregnant woman. (8/23)

 (+info)

Megacolon is a medical condition characterized by an abnormal dilation and/or hypomotility (decreased ability to move) of the colon, resulting in a significantly enlarged colon. It can be congenital or acquired. Congenital megacolon, also known as Hirschsprung's disease, is present at birth and occurs due to the absence of ganglion cells in the distal portion of the colon. Acquired megacolon, on the other hand, can develop in adults due to various causes such as chronic constipation, neurological disorders, or certain medications.

In both cases, the affected individual may experience symptoms like severe constipation, abdominal distention, and fecal impaction. If left untreated, megacolon can lead to complications such as perforation of the colon, sepsis, and even death. Treatment options depend on the underlying cause but may include medication, surgery, or a combination of both.

Toxic megacolon is a serious complication of colon inflammation that is characterized by non-obstructive dilation of the colon (diameter greater than 6 cm) and systemic toxicity. It is often associated with conditions such as inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease), infections (e.g., Clostridioides difficile infection), and ischemic colitis.

The dilation of the colon can lead to decreased blood flow, impaired motility, and increased risk of perforation, which can result in sepsis and even death if not promptly treated. The systemic toxicity may manifest as fever, tachycardia, hypotension, electrolyte imbalances, and mental status changes.

Toxic megacolon requires immediate medical attention, often involving hospitalization, intravenous fluids, antibiotics, and possibly surgical intervention to remove the affected portion of the colon.

Hirschsprung disease is a gastrointestinal disorder that affects the large intestine, specifically the section known as the colon. This condition is congenital, meaning it is present at birth. It occurs due to the absence of ganglion cells (nerve cells) in the bowel's muscular wall, which are responsible for coordinating muscle contractions that move food through the digestive tract.

The affected segment of the colon cannot relax and propel the contents within it, leading to various symptoms such as constipation, intestinal obstruction, or even bowel perforation in severe cases. Common diagnostic methods include rectal suction biopsy, anorectal manometry, and contrast enema studies. Treatment typically involves surgical removal of the aganglionic segment and reattachment of the normal colon to the anus (known as a pull-through procedure).

Chagas disease, also known as American trypanosomiasis, is a tropical parasitic disease caused by the protozoan *Trypanosoma cruzi*. It is primarily transmitted to humans through the feces of triatomine bugs (also called "kissing bugs"), which defecate on the skin of people while they are sleeping. The disease can also be spread through contaminated food or drink, during blood transfusions, from mother to baby during pregnancy or childbirth, and through organ transplantation.

The acute phase of Chagas disease can cause symptoms such as fever, fatigue, body aches, headache, rash, loss of appetite, diarrhea, and vomiting. However, many people do not experience any symptoms during the acute phase. After several weeks or months, most people enter the chronic phase of the disease, which can last for decades or even a lifetime. During this phase, many people do not have any symptoms, but about 20-30% of infected individuals will develop serious cardiac or digestive complications, such as heart failure, arrhythmias, or difficulty swallowing.

Chagas disease is primarily found in Latin America, where it is estimated that around 6-7 million people are infected with the parasite. However, due to increased travel and migration, cases of Chagas disease have been reported in other parts of the world, including North America, Europe, and Asia. There is no vaccine for Chagas disease, but medications are available to treat the infection during the acute phase and to manage symptoms during the chronic phase.

Constipation is a condition characterized by infrequent bowel movements or difficulty in passing stools that are often hard and dry. The medical definition of constipation varies, but it is generally defined as having fewer than three bowel movements in a week. In addition to infrequent bowel movements, other symptoms of constipation can include straining during bowel movements, feeling like you haven't completely evacuated your bowels, and experiencing hard or lumpy stools.

Constipation can have many causes, including a low-fiber diet, dehydration, certain medications, lack of physical activity, and underlying medical conditions such as irritable bowel syndrome or hypothyroidism. In most cases, constipation can be treated with lifestyle changes, such as increasing fiber intake, drinking more water, and getting regular exercise. However, if constipation is severe, persistent, or accompanied by other symptoms, it's important to seek medical attention to rule out any underlying conditions that may require treatment.

The sigmoid colon is a part of the large intestine that forms an "S"-shaped curve before it joins the rectum. It gets its name from its unique shape, which resembles the Greek letter sigma (σ). The main function of the sigmoid colon is to store stool temporarily and assist in the absorption of water and electrolytes from digestive waste before it is eliminated from the body.

The enteric nervous system (ENS) is a part of the autonomic nervous system that directly controls the gastrointestinal tract, including the stomach, small intestine, colon, and rectum. It is sometimes referred to as the "second brain" because it can operate independently of the central nervous system (CNS).

The ENS contains around 500 million neurons that are organized into two main plexuses: the myenteric plexus, which lies between the longitudinal and circular muscle layers of the gut, and the submucosal plexus, which is located in the submucosa. These plexuses contain various types of neurons that are responsible for regulating gastrointestinal motility, secretion, and blood flow.

The ENS can communicate with the CNS through afferent nerve fibers that transmit information about the state of the gut to the brain, and efferent nerve fibers that carry signals from the brain back to the ENS. However, the ENS is also capable of functioning independently of the CNS, allowing it to regulate gastrointestinal functions in response to local stimuli such as food intake, inflammation, or infection.

A colectomy is a surgical procedure in which all or part of the large intestine (colon) is removed. This surgery may be performed to treat or prevent various medical conditions, including colon cancer, inflammatory bowel disease, diverticulitis, and severe obstructions or injuries of the colon.

There are several types of colectomies, depending on how much of the colon is removed:

* Total colectomy: Removal of the entire colon.
* Partial colectomy: Removal of a portion of the colon.
* Hemicolectomy: Removal of one half of the colon.
* Sigmoidectomy: Removal of the sigmoid colon, which is the part of the colon that is closest to the rectum.

After the affected portion of the colon is removed, the remaining ends of the intestine are reconnected, allowing stool to pass through the digestive system as usual. In some cases, a temporary or permanent colostomy may be necessary, in which a surgical opening (stoma) is created in the abdominal wall and the end of the colon is attached to it, allowing stool to be collected in a pouch outside the body.

Colectomies are major surgeries that require general anesthesia and hospitalization. The recovery time can vary depending on the type of colectomy performed and the individual's overall health, but typically ranges from several weeks to a few months. Complications of colectomy may include bleeding, infection, leakage from the surgical site, bowel obstruction, and changes in bowel habits or function.

The rectum is the lower end of the digestive tract, located between the sigmoid colon and the anus. It serves as a storage area for feces before they are eliminated from the body. The rectum is about 12 cm long in adults and is surrounded by layers of muscle that help control defecation. The mucous membrane lining the rectum allows for the detection of stool, which triggers the reflex to have a bowel movement.

An ileostomy is a surgical procedure in which the end of the small intestine, called the ileum, is brought through an opening in the abdominal wall (stoma) to create a path for waste material to leave the body. This procedure is typically performed when there is damage or removal of the colon, rectum, or anal canal due to conditions such as inflammatory bowel disease (Crohn's disease or ulcerative colitis), cancer, or trauma.

After an ileostomy, waste material from the small intestine exits the body through the stoma and collects in a pouch worn outside the body. The patient needs to empty the pouch regularly, typically every few hours, as the output is liquid or semi-liquid. Ileostomies can be temporary or permanent, depending on the underlying condition and the planned course of treatment. Proper care and management of the stoma and pouch are essential for maintaining good health and quality of life after an ileostomy.

The colon, also known as the large intestine, is a part of the digestive system in humans and other vertebrates. It is an organ that eliminates waste from the body and is located between the small intestine and the rectum. The main function of the colon is to absorb water and electrolytes from digested food, forming and storing feces until they are eliminated through the anus.

The colon is divided into several regions, including the cecum, ascending colon, transverse colon, descending colon, sigmoid colon, rectum, and anus. The walls of the colon contain a layer of muscle that helps to move waste material through the organ by a process called peristalsis.

The inner surface of the colon is lined with mucous membrane, which secretes mucus to lubricate the passage of feces. The colon also contains a large population of bacteria, known as the gut microbiota, which play an important role in digestion and immunity.

A colostomy is a surgical procedure that involves creating an opening, or stoma, through the abdominal wall to divert the flow of feces from the colon (large intestine) through this opening and into a pouch or bag worn outside the body. This procedure is typically performed when a portion of the colon has been removed due to disease or injury, such as cancer, inflammatory bowel disease, or trauma.

There are several types of colostomies, including end colostomy, loop colostomy, and double-barrel colostomy, which differ in terms of the location and configuration of the stoma. The type of colostomy performed will depend on the individual's medical condition and the specific goals of the surgery.

After a colostomy, patients will need to learn how to care for their stoma and manage their bowel movements using specialized equipment and techniques. With proper care and management, most people are able to lead active and fulfilling lives after a colostomy.

"Toxic megacolon" at Dorlands Medical Dictionary Panos, MZ; Wood, MJ; Asquith, P (December 1993). "Toxic megacolon: The knee- ... "Toxic megacolon: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2022-11-18. "Toxic megacolon httpsmedlineplus. ... Toxic megacolon is an acute form of colonic distension. It is characterized by a very dilated colon (megacolon), accompanied by ... Toxic megacolon is usually a complication of inflammatory bowel disease, such as ulcerative colitis and, more rarely, Crohns ...
Toxic megacolon occurs when swelling and inflammation spread into the deeper layers of your colon. As a result, the colon stops ... Toxic megacolon occurs when swelling and inflammation spread into the deeper layers of your colon. As a result, the colon stops ... toxic megacolon; Crohn disease - toxic megacolon; Ulcerative colitis - toxic megacolon ... The term "toxic" means that this problem is very dangerous. Toxic megacolon may occur in people with an inflamed colon due to: ...
Toxic megacolon is the clinical term for an acute toxic colitis with dilatation of the colon. The dilatation can be either ... encoded search term (Toxic Megacolon) and Toxic Megacolon What to Read Next on Medscape ... and toxic megacolon have fallen in the last 3 decades due to multiple factors, including early recognition of toxic megacolon, ... It is important to differentiate toxic megacolon from other conditions that present with megacolon without systemic toxicity ...
The development of toxic megacolon as a complication of infectious colitis is rare. However it is recognised as a complication ... Toxic megacolon complicating Escherichia coli O157 infection.. Deepa M Nayar, Shanmu Vetrivel, Jack McElroy, Pearl Pai, Roland ... Toxic megacolon is a well known complication in inflammatory bowel disease such as ulcerative colitis or Crohns disease. ... ileo-colitis in a previously fit and healthy young adult female caused by Escherichia coli O157 where toxic megacolon developed ...
In toxic megacolon, gas becomes trapped, causing the colon to swell. When this occurs, there is a risk of colon rupture, ... However, some UC complications, such as toxic megacolon, can be life threatening. In addition, at least 5%. of people with UC ... Fulminant colitis can present a risk of colon rupture and toxic megacolon, which causes the colon to become severely distended. ... Toxic megacolon. This complication occurs in a few cases of severe UC. ...
Toxic megacolon. Toxic megacolon is a rare but life-threatening complication of IBD. Although it is more common among people ... Toxic megacolon. (n.d.). https://www.hopkinsmedicine.org/healthlibrary/conditions/digestive_disorders/toxic_megacolon_134,180. ... Toxic megacolon occurs when inflammation causes the colon to expand to such an extent that it cannot contract. The result is a ... Recognizing indications of toxic megacolon and receiving prompt treatment can reduce the risk of life-threatening complications ...
A toxic megacolon is a rare yet life-threatening complication of severe colon disease or infection. It is diagnosed when your ...
Tag: toxic megacolon. Deadly Care: New Study Outlines Just How Dangerous Hospitals Are To Your Health. September 13, 2016. ...
Antibiotic‐Associated Fulminant Pseudomembranous Colitis without Toxic Megacolon. Barry E. Herman, John Vargo, W. Stephen ... Antibiotic‐Associated Fulminant Pseudomembranous Colitis without Toxic Megacolon. In: American Journal of Gastroenterology. ... Antibiotic‐Associated Fulminant Pseudomembranous Colitis without Toxic Megacolon. / Herman, Barry E.; Vargo, John; Phillips, W ... Antibiotic‐Associated Fulminant Pseudomembranous Colitis without Toxic Megacolon. American Journal of Gastroenterology. 1992 ...
Toxic megacolona. 20. ,1. Ileusa. 142. 2. Pseudomembranous colitisa. 29. ,1. ...
toxic megacolon *uncontrolled bleeding Though surgery can help many people living with Crohns disease, all operations involve ...
Amebiasis is caused by Entamoeba histolytica (see the image below), a protozoan that is found worldwide (see Etiology). The highest prevalence of amebiasis is in developing countries where barriers between human feces and food and water supplies are inadequate (see Epidemiology).
Serious intestinal condition, such as toxic megacolon. Sepsis, the bodys extreme response to an infection ...
Toxic colitis and toxic megacolon. *Gastric retention. *Ileus. Clinical Pharmacology. CLINICAL PHARMACOLOGY. Mechanism Of ...
Toxic Megacolon. Johns Hopkins Medicine.. *Colombel JF, Sandborn WJ, Ghosh S, et al. Four-Year Maintenance Treatment With ...
the bowel widens and swells up (called toxic megacolon). *the bleeding cant be stopped ...
Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum. 1995; 38: 1033-1038.. * Cited Here , ...
Salmonella dysenteric patients: due to risk of toxic megacolon ( 5.6) * Ulcerative colitis: Dicyclomine hydrochloride should be ... 5.6 Toxic Dilatation of Intestinemegacolon. Toxic dilatation of intestine and intestinal perforation is possible when ... large doses may suppress intestinal motility or aggravate the serious complications of toxic megacolon ( 5.7) ... 5.6 Toxic Dilatation of Intestinemegacolon 5.7 Ulcerative Colitis 5.8 Prostatic Hypertrophy 5.9 Hepatic and Renal Disease 5.10 ...
Toxic colitis (a poisonous and inflamed large bowel). *Toxic megacolon (a poisonous and enlarged large bowel) ...
... megacolon and toxic megacolon. Imodium must be discontinued promptly when ileus, constipation or abdominal distension develop. ... There have been isolated reports of obstipation with an increased risk for toxic megacolon in AIDS patients with infectious ... Bullous eruptiona (including Stevens-Johnson syndrome, Toxic epidermal necrolysis and Erythema multiforme) ...
... symptoms range from mild diarrhea to life-threatening colitis and toxic megacolon. CDI is associated with a high mortality rate ...
Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis. Levsin/sl Boxed Warnings. Not Applicable ...
In ulcerative colitis, large doses may suppress intestinal motility and exacerbate an ileus or toxic megacolon; use is ... toxic megacolon, myasthenia gravis, reflux esophagitis, hiatal hernia, mitral stenosis). *Concomitant use of solid oral dosage ...
Gastrointestinal system: toxic megacolon, paralytic ileus, pancreatitis, vomiting, nausea, anorexia, abdominal discomfort. ... agents that inhibit intestinal motility or prolong intestinal transit time have been reported to induce toxic megacolon. ...
Salmonella dysenteric patients: Due to risk of toxic megacolon. Use caution in patients with mild-moderate ulcerative colitis ...
Known or suspected toxic megacolon and/or known small bowel ileus.. *Prior history, evidence, or diagnosis of inflammatory ...
Recurrent C. diff colitis, toxic megacolon. *Thrombosed hemorrhoids. *Ulcerative colitis. *Vaginal agenesis ...
Toxic megacolon in Salmonella colitis (Acta Paediatr Taiwan 2000;41:43). *Typhoidal Salmonella: *10 year old child with ... 62 year old man with toxic megacolon due to Salmonella (Int J Colorectal Dis 2002;17:275) *Family outbreaks of nontyphoidal ... Very rarely, toxic megacolon may complicate infection *Individuals with achlorhydria or hypochlorhydria from drugs, chronic ...
If its an emergency, such as a problem like toxic megacolon.. *If medicines dont help your symptoms, or if side effects are ...

No FAQ available that match "megacolon toxic"

No images available that match "megacolon toxic"